Pipamperone: International drug information (concise)

For abbreviations, symbols, and age group definitions show table

International Brand Names

International Brand Names by Country

For country code abbreviations (show table)

(BE) Belgium: Dipiperon;
(CH) Switzerland: Dipiperon;
(DE) Germany: Dipiperon | Pipamperon | Pipamperon 1 a pharma | Pipamperon hexal | Pipamperon neuraxpharm;
(FR) France: Dipiperon;
(GR) Greece: Dipiperon;
(IT) Italy: Piperonil;
(JP) Japan: Propitan;
(LT) Lithuania: Pipamperon 1a pharma;
(LU) Luxembourg: Dipiperon;
(NL) Netherlands: Dipiperon | Pipamperon | Pipamperon sandoz;
(PL) Poland: Dipiperon;
(TN) Tunisia: Dipiperon

Index Terms

Pipamperone Hydrochloride

Pharmacologic Category

Antipsychotic Agent, Butyrophenone

Reported Use

Treatment of psychomotor agitation related to schizophrenia and other psychotic disorders, and management of sleep disorders particularly in older patients.

Dosage Range

Agitation:

Adults: Oral: 40 mg once to 3 times daily to a maximum of 120 mg 3 times daily.

Pediatric:

Children <14 years: Oral: 1 to 4 mg/kg/day in 3 divided doses (maximum: 6 mg/kg/day).

Adolescents ≥14 years: Oral: 20 to 40 mg 1 to 3 times daily (maximum: 120 mg 3 times daily).

Sleep disorders:

Adults: Oral: 40 mg to 80 mg once daily at bedtime (maximum: 320 mg/day).

Adolescents ≥14 years: Oral: 20 to 80 mg once daily at bedtime (maximum: 320 mg/day).

Product Availability

Product available in various countries; not currently available in the United States.

Dosage Forms

Solution, Oral: 4 mg/mL

Tablet, Oral: 40 mg

Topic 10456 Version 45.0

خرید پکیج

Pipamperone: International drug information (concise)